Studies supporting a strong association between tau deposition and neuronal loss, neurodegeneration, and cognitive decline have heightened the allure of tau and tau-related mechanisms as therapeutic targets. In February 2020, leading tau experts from around the world convened for the first-ever Tau2020 Global Conference in Washington, DC, co-organized and cosponsored by the Rainwater Charitable Foundation, the Alzheimer's Association, and CurePSP. Representing academia, industry, government, and the philanthropic sector, presenters and attendees discussed recent advances and current directions in tau research. The meeting provided a unique opportunity to move tau research forward by fostering global partnerships among academia, industry, and other stakeholders and by providing support for new drug discovery programs, groundbreaking research, and emerging tau researchers. The meeting also provided an opportunity for experts to present critical research-advancing tools and insights that are now rapidly accelerating the pace of tau research.

中文翻译：

---

tau 研究的当前方向：Tau 2020 的亮点

支持 tau 沉积与神经元丢失、神经变性和认知能力下降之间密切相关的研究增强了 tau 和 tau 相关机制作为治疗靶点的吸引力。2020 年 2 月，来自世界各地的主要 tau 专家在华盛顿特区召开了首届 Tau2020 全球会议，会议由雨水慈善基金会、阿尔茨海默氏症协会和 CurePSP 共同组织和赞助。代表学术界、工业界、政府和慈善部门的演讲者和与会者讨论了 tau 研究的最新进展和当前方向。这次会议通过促进学术界、工业界和其他利益相关者之间的全球伙伴关系，并通过为新药发现计划、开创性研究、和新兴的 tau 研究人员。会议还为专家们提供了一个展示关键研究推进工具和见解的机会，这些工具和见解正在迅速加快 tau 研究的步伐。